Furthermore, effective anti-cancer strategies involving LRP5-directed therapies remains a current conundrum, as Wnt signaling orchestrates normal bone formation and LRP5 expression in osteoclasts results in tumor-suppression [122]. The gene discussed is LRP5; the disease is neoplasm.